KROS (Keros Therapeutics) Short Interest


KROS Keros Therapeutics Inc KROS
30 GF Score
Price $10.92
! 3 Warning Signs
View Full Analysis

What is Keros Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

KROS vs RNA, RNAC, ARCT: Short Interest Comparison

For the Biotechnology subindustry, Keros Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keros Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keros Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Keros Therapeutics's Short Interest falls into.


KROS
30GF Score
Keros Therapeutics Inc KROS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Keros Therapeutics Business Description

Address 1050 Waltham Street, Suite 302, Lexington, MA, USA, 02421
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
30GF Score

Get the complete analysis for KROS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.92
Price